However, BCR/ABL1-expressing DCs have been detected in the peripheral blood of CML patients suggesting that CML derived DCs may possibly contribute to anti-leukemic immunity (81, 82). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.